2016～2018年泌尿外科患者尿路感染病原菌分布及耐药性分析

陈中举; 田磊; 杨为民; 刘征

doi:10.13201/j.issn.1001-1420.2020.02.004

2016～2018年泌尿外科患者尿路感染病原菌分布及耐药性分析

- 1. 华中科技大学同济医学院附属同济医院检验科(武汉, 430030);
- 2. 华中科技大学同济医学院附属同济医院泌尿外科
基金项目:
湖北省自然科学基金一般面上项目资助(No:2019CFB666)

详细信息

通讯作者: 刘征,E-mail:lz2013tj@163.com

中图分类号: R691.3

收稿日期: 2019-02-13

Analysis of pathogenic bacterium distribution and antibiotic resistance among urologic patients with urinary infection in 2016-2018

- 1. Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China;
- 2. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

More Information

Corresponding author: LIU Zheng, E-mail: lz2013tj@163.com

Received Date: 13 February 2019

摘要

摘要: 目的:对泌尿外科患者尿路感染的病原菌分布及耐药性进行分析,给临床治疗提供依据。方法:收集2016年1月~2018年12月我院泌尿外科患者尿路感染病原菌2 597株,使用MALDI-TOF飞行质谱仪进行菌株的鉴定,采用纸片扩散法进行药敏试验,采用WHONET 5.6软件进行耐药率分析,使用SPSS统计软件进行χ²检验和统计分析。结果:分离革兰阴性菌1 860株,革兰阳性菌520株,念珠菌217株,分别占71.6%、20%和8.4%。大肠埃希菌、屎肠球菌、念珠菌属、粪肠球菌和肺炎克雷伯菌排在前5位,分别占总菌株数的46.5%、8.7%、8.4%、7.9%和7.5%。大肠埃希菌和肺炎克雷伯菌的ESBLs发生率分别为59.4%和43.3%。与2016年相比,2018年分离的大肠埃希菌对头孢哌酮/舒巴坦、哌拉西林/他唑巴坦、亚胺培南、庆大霉素、妥布霉素和呋喃妥因的耐药率显著降低。肺炎克雷伯菌、铜绿假单胞菌、屎肠球菌和粪肠球菌对各种抗菌药物的耐药率在3年之间未显示出显著性差异。大肠埃希菌及肺炎克雷伯菌对哌拉西林、头孢噻肟、头孢唑啉、头孢吡肟、环丙沙星、左旋氧氟沙星等耐药率多在60%以上。粪肠球菌对环丙沙星和左氧氟沙星的耐药率分别为24.0%和22.4%,屎肠球菌对环丙沙星和左氧氟沙星的耐药率分别为97.7%和96.8%。结论:泌尿外科患者尿路感染的主要病原菌为肠杆菌科细菌中的大肠埃希菌和肺炎克雷伯菌,且产超广谱β内酰胺酶菌株检出率较高。此外,屎肠球菌、粪肠球菌、念珠菌也是常见分离菌。临床医生要密切关注分离菌的变迁及耐药性情况,合理使用抗菌药物。
- 泌尿外科患者 /
- 尿路感染 /
- 病原菌 /
- 抗菌药物
Abstract: Objective: To analyze pathogenic bacterium distribution and antibiotic resistance among urologic patients with urinary infection to provide evidence for clinical treatment. Method: A total of 2597 uropathogens were collected in our hospital from January 2016 to December 2018. Identification of strains and drug sensitivity test were performed by MALDI-TOF flight mass spectrometer and paper diffusion method respectively. Statistical analysis was performed using WHONET 5.6 software. Chi-square test was performed by SPSS software. Result: The uropathogens comprised 1860(71.6%) gram-negative bacteria, 520(20%) gram-positive bacteria and 217(8.4%) Candida. The five most common bacteria were Escherichia coli(46.5%), Enterococcus faecium(8.7%), Candida spp.(8.4%), Enterococcus faecalis(7.9%) and Klebsiella pneumoniae(7.5%). The incidence rate of ESBLs in Escherichia coli and Klebsiella pneumoniae were 59.4% and 43.3% respectively. Compared with 2016, the antibiotic resistance rate of Escherichia coli isolated in 2018 to cefoperazone/sulbactam, piperacillin/tazobactam, imipenem, gentamicin, tobramycin and nitrofurantoin was much lower. The antibiotic resistance rates of Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecium and Enterococcus faecalis to various antibiotics did not show significant difference among three years. The antibiotic resistance rates of Escherichia coli and Klebsiella pneumoniae to piperacillin, cefotaxime, cefazolin, cefepime, ciprofloxacin and levofloxacin were more than 60%. The antibiotic resistance rates of Enterococcus faecalis to ciprofloxacin and levofloxacin were 24.0% and 22.4%, while Enterococcus faecium were as high as 97.7% and 96.8%.Conclusion: The main pathogens of urinary infection in urological patients are Escherichia coli and Klebsiella pneumoniae in Enterobacteriaceae, and the detection rate of ESBLs strain is high. Besides, Enterococcus faecium, Enterococcus faecalis and Candida spp. are also common pathogens. Clinicians should pay close attention to the changes and antibiotic resistance of isolated bacteria and reasonably use antibiotics.
- urologic patient /
- urinary infection /
- bacteria /
- antibiotic

HTML全文

参考文献(13)

[1]	卓树洪,叶晓光,廖云珍,等.泌尿感染菌群分布及耐药性分析[J].中华生物医学工程杂志,2016,22(1):76-80.
[2]	李文波,高武,王周宝,等.泌尿系统感染革兰阴性杆菌的病原学分布及耐药表型[J].中国感染与化疗杂志,2017,17(2):167-170.
[3]	Fasugba O,Mitchell BG,Mnatzaganian G,et al.Five-year antimicrobial resistance patterns of urinary Escherichia coli at an Australian tertiary hospital:time series analyses of prevalence data[J].PLoS One,2016,11(10):e0164306.
[4]	Köves B,Cai T,Veeratterapillay R,et al.Benefits and harms of treatment of asymptomatic bacteriuria:a systematic review and meta-analysis by the European association of urology urological infection guidelines panel[J].Eur Urol,2017,72(6):865-868.
[5]	Sorlozano A,Jimenez-pacheco A,de Dios Luna Delastillo J,et al.Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections:a 7-year surveillance study[J].Am J Infect Control,2014,42(10):1033-1038.
[6]	Gibold L,Robin F,Tan RN,et al.Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital[J].Clin Microbiol Infect,2014,20(1):20-26.
[7]	Mody L,Gibson KE,Horcher A,et al.Prevalence of and risk factors for multidrug-resistant acinetobacter baumannii colonization among high-risk nursing home residents[J].Infect Control Hosp Epidemiol,2015,36(10):1155-1162.
[8]	Fatima S,Muhammad IN,Usman S,et al.Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients[J].Indian J Phamacol,2018,50(2):69-74.
[9]	胡付品,郭燕,朱德妹,等.2017年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251.
[10]	Seroy JT,Grim SA,Reid GE,et al.Treatment of MDR urinary tract infections with oral fosfomycin:a retrospective analysis[J].J Antimicrob Chemother,2016,71(9):2563-2568.
[11]	Chen D,Zhang Y,Huang J,et al.The analysis of microbial spectrum and antibiotic resistance of uropathogens isolated from patients with urinary stones[J].Int J Clin Pract,2018,72(6):e13205.
[12]	Clifford TG,Katebian B,Van Horn CM,et al.Urinary tract infections following radical cystectomy and urinary diversion:a review of 1133 patients[J].World J Urol,2018,36(5):775-781.
[13]	Pappas PG,Kauffman CA,Andes DR.et al.Clinical Practice Guideline for the Management of Candidiasis:2016 Update by the Infectious Diseases Society of America[J].Clin Infect Dis,2016,62(4):409-417.